Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Schnabl

Showing results (71-80 of 283) with videos related to

Pageof 29
Sort By:
Gut|September 2, 2018
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver diseaseHuikuan Chu, Yi Duan, Ling Yang, et al.
Molecular Nutrition & Food Research|June 26, 2020
Microbial Products and Metabolites Contributing to Alcohol-Related Liver DiseaseBei Gao, Atoosa Emami, Shilpa Nath, et al.
Experimental and Molecular Pathology|August 16, 2011
Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migrationBernd Schnabl, Daniela Valletta, Georgi Kirovski, et al.
The Journal of Clinical Investigation|April 1, 2025
Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovationsBernd Schnabl, Christopher J Damman, Rotonya M Carr
Journal of Clinical Gastroenterology|October 9, 2015
Role of Gut Microbiota in Liver DiseaseDavid A Brenner, Yong-Han Paik, Bernd Schnabl
World Journal of Gastroenterology|September 21, 2020
Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in miceSena Bluemel, Yanhan Wang, Suhan Lee, et al.
Hepatology (Baltimore, Md.)|April 6, 2023
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019Phillipp Hartmann, Xinlian Zhang, Rohit Loomba, et al.
Methods and Protocols|November 21, 2023
Development of a Quantitative PCR Method for Detecting <i>Enterococcus faecalis</i> Cytolysin in Human Stool SamplesNoemí Cabré, Yongqiang Yang, Yanhan Wang, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 16, 2019
Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful eitherPhillipp Hartmann, Huikuan Chu, Yi Duan, et al.
International Journal of Molecular Sciences|December 10, 2021
Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver DiseaseLuca Maccioni, Isabelle A Leclercq, Bernd Schnabl, et al.
Pageof 29

Showing results (71-80 of 283) with videos related to

Sort By:
Pageof 29
Gut|September 2, 2018
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver diseaseHuikuan Chu, Yi Duan, Ling Yang, et al.
Molecular Nutrition & Food Research|June 26, 2020
Microbial Products and Metabolites Contributing to Alcohol-Related Liver DiseaseBei Gao, Atoosa Emami, Shilpa Nath, et al.
Experimental and Molecular Pathology|August 16, 2011
Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migrationBernd Schnabl, Daniela Valletta, Georgi Kirovski, et al.
The Journal of Clinical Investigation|April 1, 2025
Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovationsBernd Schnabl, Christopher J Damman, Rotonya M Carr
Journal of Clinical Gastroenterology|October 9, 2015
Role of Gut Microbiota in Liver DiseaseDavid A Brenner, Yong-Han Paik, Bernd Schnabl
World Journal of Gastroenterology|September 21, 2020
Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in miceSena Bluemel, Yanhan Wang, Suhan Lee, et al.
Hepatology (Baltimore, Md.)|April 6, 2023
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019Phillipp Hartmann, Xinlian Zhang, Rohit Loomba, et al.
Methods and Protocols|November 21, 2023
Development of a Quantitative PCR Method for Detecting <i>Enterococcus faecalis</i> Cytolysin in Human Stool SamplesNoemí Cabré, Yongqiang Yang, Yanhan Wang, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 16, 2019
Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful eitherPhillipp Hartmann, Huikuan Chu, Yi Duan, et al.
International Journal of Molecular Sciences|December 10, 2021
Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver DiseaseLuca Maccioni, Isabelle A Leclercq, Bernd Schnabl, et al.
Pageof 29